Posted on 3/6/20
Karyopharm Therapeutics: All Systems Go
SummaryThe stock of Karyopharm Therapeutics had soared over 60% since we said to 'buy the dip' in an article last month.Late stage key trial results just . . .
Posted on 2/18/20
Karyopharm Therapeutics: Pullback Is Overdone
SummaryThe stock of Karyopharm Therapeutics has seen an approximate 20% pullback in recent weeks but reported solid Q4 results Thursday.We take a look at fourth-quarter numbers . . .
Posted on 1/31/20
Stemline Therapeutics: Down, But Not Out
SummaryToday we revisit Stemline Therapeutics, whose stock has fallen some 35% this month on disappointing preliminary Q4 revenue guidance.However, the company's ELZONRIS franchise and the stock . . .
Posted on 1/27/20
EyePoint Pharmaceuticals: Gaining Traction
SummaryEyePoint Pharmaceuticals posted preliminary fourth quarter and full year 2019 revenue guidance on Thursday.Data showed the company has shown considerable progress ramping up sales in its . . .
Posted on 11/26/19
Sizing Up Verrica Pharmaceuticals
SummaryLittle-known and thinly-traded busted IPO Verrica Pharmaceuticals Inc. filed an NDA for its candidate VP-102 in the treatment of molluscum contagiosum in September 2019.Approval, which appears . . .
Posted on 5/17/19
GlycoMimetics: An Investment Update
Summary Today, we look at an interesting small-cap developmental concern with a couple of compounds in late-stage development. This developmental concern is well-funded and getting increasing . . .
Posted on 5/17/19
GlycoMimetics: An Investment Update
SummaryToday, we look at an interesting small-cap developmental concern with a couple of compounds in late-stage development.This developmental concern is well-funded and getting increasing positive analyst . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
Summary Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the . . .
Posted on 1/29/19
Newmark: Can The Rally Continue?
SummaryCommercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018.Fears of higher interest rates and the anticipation of . . .
Posted on 1/28/19
An Investment View On Newmark
Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the anticipation . . .
Posted on 1/28/19
An Investment View On Newmark
Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the anticipation . . .
Posted on 1/28/19
An Investment View On Newmark
Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018. Fears of higher interest rates and the anticipation . . .
Posted on 1/28/19
An Investment View On Newmark
Commercial real estate company Newmark Group was completely spun out of BGC Partners, Inc. on November 30th, 2018.Fears of higher interest rates and the anticipation of . . .
Posted on 9/28/18
Verastem: Post FDA Approval Investment Thesis
SummaryEarlier this week, the primary oncology drug candidate from Verastem was approved by the FDA.The stock has demonstrated some "buy the rumor, sell the news" trading . . .
Posted on 6/19/18
Karyopharm: Can Its Big Rally Continue?
The stock of a one time 'Busted IPO' and 'Tier 4' biotech concern continued its impressive rally last week and is up again Monday in early . . .
Posted on 5/4/18
KaryoPharma Therapeutics: A Strong Horse In A Weak Market
"The most critical time in any battle is not when I'm fatigued, it's when I no longer care." - Craig D. LounsbroughToday, we take a look . . .
Posted on 10/4/17
Akari Therapeutics: What's Next For This 'Busted IPO'?
Today we look at a small-cap concern I received a question on from a Biotech Forum member last week that I had not previously researched. It . . .
Atlanta
